Recurrent cardiac drug-eluting stent thrombosis due to antiphospholipid syndrome: a case report

In APS, there is an increased risk of thrombosis episodes in addition to pre-existing patient factors. Major thrombotic episodes are at risk, and these risks need to be stratified according to individual patient factors. Early involvement of multidisciplinary team and adequate anticoagulation could have prevented acute recurrent stent thrombosis.